
Cipher Pharmaceuticals to release Q3 results Nov. 6
Cipher Pharmaceuticals to release Q3 results Nov. 6

Cipher Pharmaceuticals to release Q3 results Nov. 6
Quantum BioPharma Ltd. Announces Corporate Updates
VVT Med Receives Order from Major US Healthcare Network NorthWell Health and Enters Into Investor Relations Agreements
Ventripoint to test AI-enhanced echocardiography
Bausch Health Announces Third Quarter 2025 Results
XORTX closes $1.1-million (U.S.) direct offering
Helix BioPharma Corp. Announces Fiscal 2025 Year-End Results
Conavi gets Ontario funding for imaging system launch
Netramark presents AI findings in depression trials
Ventripoint Diagnostics and Providence Health Care Ventures Announce Collaboration to Validate AI-Enabled Cardiac Imaging at St. Paul's Hospital
Conavi Medical announces agreement with the Province of Ontario as part of the Life Sciences Scale-Up Fund
XORTX Announces Closing of US$1.1 Million Registered Direct Offering
Bausch + Lomb Announces Third-Quarter 2025 Results
NetraMark Presents AI-Driven Advances in Precision Psychiatry to Enhance Clinical Trial Designs at Joint Autumn Conference
Cybin arranges $175-million (U.S.) offering